Cold chain: difference between revisions
Diff·revision 53 → 54·07:37, 6 May 2025
Difference between revision 53 and revision 54 of Cold chain. 5 lines changed; the page grew by 570 bytes.
| Revision 53 — 02:28, 28 Apr 2025 ManualOfStyleMo (talk) attribute range as a review estimate per talk 20,418 bytes ±0 | Revision 54 — 07:37, 6 May 2025 CouplingCillian (talk) correct percentage: source reports placebo-adjusted 20,988 bytes +570 | ||
|---|---|---|---|
| 149 | <ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003).</ref> | 149 | <ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003).</ref> |
| 150 | 150 | ||
| + | 151 | == Further reading == | |
| + | 152 | * World Health Organization. ''Technical Supplements to WHO Technical Report Series 961, Annex 9'' (2015) — individually addressed operations including temperature mapping and shipper qualification. | |
| + | 153 | * Kartoglu U, Ames H. "Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring." ''Human Vaccines and Immunotherapeutics'' (2022). | |
| + | 154 | * Bishara RH. "Cold chain management — an essential component of the global pharmaceutical supply chain." ''American Pharmaceutical Review'' 9(1):105–109 (2006). | |
| + | 155 | ||
| 151 | == See also == | 156 | == See also == |
| 152 | * [[Temperature excursion]] | 157 | * [[Temperature excursion]] |